PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsIndivior
Indivior(INDV)
Indivior is a specialty pharmaceuticals business. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
BuprenexBuprenorphine hydrochloride1982-01-01
—
PerserisRisperidone2018-07-272025-2033
SublocadeBuprenorphine2017-11-302024-2038
SuboxoneNaloxone, Buprenorphine hydrochloride, Buprenorphine2002-10-082024-2041
SubutexBuprenorphine hydrochloride2002-10-08
—
OpveeNalmefene2023-05-222038
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Buprenorphine
Naloxone
Risperidone
Nepidermin
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use